iPS細胞製造の世界市場規模は、2028年までに17億6,000万米ドルに達し、予測期間中のCAGRは8.0%となる見込みです。市場を牽引しているのは、人工多能性細胞の製造技術の進歩、その治療効果に対する認識の高まり、人工多能性細胞を用いた再生医療の開発に関する広範な研究などです。iPS細胞は、最大限の多様性を持って分化することができるため、遺伝子治療や細胞治療への応用を促進する重要な要因の一つとなっています。
iPS細胞は高い治療効果が期待できるため、ここ数年でその用途が拡大し、市場の収益に大きく貢献しています。例えば、iPS細胞由来のエクソソームの研究、創薬を目的としたオルガノイドの作製、iPSCを用いたワクチンの研究などが行われています。iPS細胞は無限に増殖することができるため、再生医療における革新的な細胞ベースの治療法の実用化に道を開きました。また、iPS細胞は、ヒト胚性幹細胞の倫理的制約を効果的に回避し、免疫拒絶、汚染、感染のリスクを低減することから、再生医療や治療への応用が拡大しています。
人工多能性細胞を用いた臨床試験の対象疾患としては、心筋虚血や心不全などの心疾患と並んで、変性眼疾患が最も多く、次いで、脊髄損傷や神経障害-パーキンソン病、再生不良性貧血による血小板減少症などが挙げられます。さらに、iPS細胞製造用の自動化プラットフォームの人気が高まっていることも、業界の成長に貢献しています。自動化された製造プラットフォームは、コスト削減とスループットの向上に加えて、細胞の信頼性の高い再現性という理想的な機会を提供します。
iPS細胞産業の主要企業は、この市場がもたらす利益の機会を認識しており、その存在感を高めるためにM&Aに注力しています。2021年3月、Axol Biosciences社はCenso Biotechnology社との合併契約を締結しました。この事業体は、創薬・スクリーニング市場向けのiPS細胞ベースの免疫細胞、神経科学、心臓モデリングの製品・サービスを提供する主要企業の一つとなる予定です。
目次
Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’S Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increase in demand for iPSC over embryonic stem cells (ESCs)
3.2.1.2 Rise in the integration of automation in iPSC production
3.2.1.3 Expanding exploitation of iPSC in research
3.2.2 Market Restraint Analysis
3.2.2.1 Lack of standardized & regulated delivery of stem cell therapy
3.2.2.2 Scalable manufacturing of iPSC
3.2.3 Market Opportunity Analysis
3.2.3.1 Robust pipeline for iPSC
3.2.3.1 Use of iPSC in regenerative medicine
3.3 Penetration & Growth Prospect Mapping for Applications, 2020
3.4 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5 Industry Analysis - Porter’s
3.6 COVID-19 Impact Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Technological Collaborations
3.7.3 Licensing & Partnership
3.7.4 Strategic Divestments
3.8 Public Companies
3.8.1 Competitive Dashboard Analysis
3.8.2 Market Differentiators
3.9 Private Companies
3.9.1 List Of Emerging Players
3.9.2 Funding Outlook
Chapter 4 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Process Business Analysis
4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Process Movement Analysis
4.2 Manual iPSC Production Process
4.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Manual iPSC Production Process, 2017 - 2028 (USD Million)
4.3 Automated iPSC Production Process
4.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Automated iPSC Production Process, 2017 - 2028 (USD Million)
Chapter 5 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Workflow Business Analysis
5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Workflow Movement Analysis
5.2 Reprogramming
5.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Reprogramming, 2017 - 2028 (USD Million)
5.3 Cell Culture
5.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Cell Culture, 2017 - 2028 (USD Million)
5.4 Cell Characterization/Analysis
5.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Cell Characterization/Analysis, 2017 - 2028 (USD Million)
5.5 Engineering
5.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Engineering, 2017 - 2028 (USD Million)
5.6 Other
5.6.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Other Workflows, 2017 - 2028 (USD Million)
Chapter 6 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Product Business Analysis
6.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Product Movement Analysis
6.2 Instruments/Devices
6.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Instruments/Devices, 2017 - 2028 (USD Million)
6.3 Automated Platforms
6.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Automated Platforms, 2017 - 2028 (USD Million)
6.4 Consumables & Kits
6.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Consumables & Kits, 2017 - 2028 (USD Million)
6.4.2 Media
6.4.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Media, 2017 - 2028 (USD Million)
6.4.3 Kits
6.4.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Kits, 2017 - 2028 (USD Million)
6.4.4 Others
6.4.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Others, 2017 - 2028 (USD Million)
6.5 Services
6.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Services, 2017 - 2028 (USD Million)
Chapter 7 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Application Business Analysis
7.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Application Movement Analysis
7.2 Drug Development And Discovery
7.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Drug Development And Discovery, 2017 - 2028 (USD Million)
7.3 Regenerative Medicine
7.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Regenerative Medicine, 2017 - 2028 (USD Million)
7.4 Toxicology Studies
7.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Toxicology Studies, 2017 - 2028 (USD Million)
7.5 Others
7.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Other Applications, 2017 - 2028 (USD Million)
Chapter 8 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: End-Use Business Analysis
8.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: End-use Movement Analysis
8.2 Research & Academic Institutes
8.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Research & Academic Institutes, 2017 - 2028 (USD Million)
8.3 Biotechnology & Pharmaceutical Companies
8.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Biotechnology & Pharmaceutical Companies, 2017 - 2028 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Hospitals & Clinics, 2017 - 2028 (USD Million)
Chapter 9 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Regional Business Analysis
9.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.2.2.2 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.2.2.3 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.2.2.4 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.2.2.5 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.2.3.2 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.2.3.3 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.2.3.4 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.2.3.5 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.2.2 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.2.3 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.2.4 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.2.5 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.3.2 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.3.3 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.3.4 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.3.5 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.4.2 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.4.3 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.4.4 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.4.5 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.5 Spain
9.3.5.1 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.5.2 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.5.3 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.5.4 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.5.5 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.6 Italy
9.3.6.1 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.6.2 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.6.3 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.6.4 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.6.5 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.2.2 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.2.3 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.2.4 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.2.5 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.3.2 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.3.3 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.3.4 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.3.5 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.4.2 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.4.3 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.4.4 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.4.5 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.5.2.2 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5.2.3 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.5.2.4 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.5.2.5 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.5.3.2 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5.3.3 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.5.3.4 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.5.3.5 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.6 Middle East & Africa (MEA)
9.6.1 Middle East & Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.6.2.2 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6.2.3 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.6.2.4 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.6.2.5 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.6.3.2 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6.3.3 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.6.3.4 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.6.3.5 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
Chapter 10 Company Profile
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 LONZA
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 AXOL BIOSCIENCES LTD.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 EVOTEC
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 HITACHI LTD.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 REPROCELL INC.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 FATE THERAPEUTICS.
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 THERMO FISHER SCIENTIFIC, INC.
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 MERCK KGAA (MILLIPORESIGMA)
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 STEMCELLFACTORY III
10.3.9.1 Company Overview
10.3.9.2 Osiris Therapeutics Inc.
10.3.9.3 Financial Performance
10.3.9.4 Product Benchmarking
10.3.9.5 Strategic Initiatives
10.3.10 APPLIED STEMCELL INC.
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.5 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 3 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 4 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 5 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 6 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 7 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 8 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 9 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 10 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 11 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 12 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 13 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 14 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 15 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 16 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 17 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 18 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 19 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 20 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 21 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 22 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 23 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 24 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 25 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 26 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 27 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 28 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 29 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 30 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 31 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 32 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 33 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 34 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 35 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 36 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 37 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 38 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 39 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 40 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 41 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 42 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 43 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 44 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 45 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 46 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 47 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 48 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 49 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 50 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 51 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 52 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 53 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 54 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 55 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 56 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 57 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 58 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 59 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 60 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 61 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 62 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 63 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 64 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 65 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 66 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 67 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 68 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 69 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 70 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 71 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 72 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 73 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 74 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 75 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 76 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 77 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 78 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 79 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 80 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 81 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 82 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 83 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 84 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 85 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 86 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 87 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 88 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 89 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 90 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 91 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 92 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 93 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 94 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 95 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 96 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 97 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 98 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 99 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 100 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 101 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 102 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 103 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 104 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 105 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 106 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 107 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 108 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 109 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
Table 110 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017 - 2028 (USD Million)
Table 111 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017 - 2028 (USD Million)
Table 112 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017 - 2028 (USD Million)
Table 113 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017 - 2028 (USD Million)
Table 114 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017 - 2028 (USD Million)
Table 115 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market trends & outlook
Fig. 9 Induced pluripotent stem cell (iPSC) production/generation market driver impact
Fig. 10 Induced pluripotent stem cell (iPSC) production/generation market restraint impact
Fig. 11 Induced pluripotent stem cell (iPSC) production/generation market restraint impact
Fig. 12 Penetration & growth prospect mapping for products, 2020
Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Induced pluripotent stem cell (iPSC) production/generation market: Process outlook and key takeaways
Fig. 16 Induced pluripotent stem cell (iPSC) production/generation market: Process movement analysis
Fig. 17 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for manual iPSC production process, 2017 - 2028 (USD Million)
Fig. 18 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for automated iPSC production process, 2017 - 2028 (USD Million)
Fig. 19 Induced pluripotent stem cell (iPSC) production/generation market: Workflow outlook and key takeaways
Fig. 20 Induced pluripotent stem cell (iPSC) production/generation market: Workflow movement analysis
Fig. 21 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for reprogramming, 2017 - 2028 (USD Million)
Fig. 22 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for cell culture, 2017 - 2028 (USD Million)
Fig. 23 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for cell characterization/analysis, 2017 - 2028 (USD Million)
Fig. 24 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for engineering, 2017 - 2028 (USD Million)
Fig. 25 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for other workflows, 2017 - 2028 (USD Million)
Fig. 26 Induced pluripotent stem cell (iPSC) production/generation market: Product outlook and key takeaways
Fig. 27 Induced pluripotent stem cell (iPSC) production/generation market: Product movement analysis
Fig. 28 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for Instruments/devices, 2017 - 2028 (USD Million)
Fig. 29 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for media, 2017 - 2028 (USD Million)
Fig. 30 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for kits, 2017 - 2028 (USD Million)
Fig. 31 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for other consumables, 2017 - 2028 (USD Million)
Fig. 32 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for automated platforms, 2017 - 2028 (USD Million)
Fig. 33 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for consumables & kits, 2017 - 2028 (USD Million)
Fig. 34 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for services, 2017 - 2028 (USD Million)
Fig. 35 Induced pluripotent stem cell (iPSC) production/generation market: Application outlook and key takeaways
Fig. 36 Induced pluripotent stem cell (iPSC) production/generation market: Application movement analysis
Fig. 37 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for drug development and discovery, 2017 - 2028 (USD Million)
Fig. 38 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for regenerative medicine, 2017 - 2028 (USD Million)
Fig. 39 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for toxicology studies, 2017 - 2028 (USD Million)
Fig. 40 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for others, 2017 - 2028 (USD Million)
Fig. 41 Induced pluripotent stem cell (iPSC) production/generation market: End-use outlook and key takeaways
Fig. 42 Induced pluripotent stem cell (iPSC) production/generation market: End-use movement analysis
Fig. 43 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for research and academic institutes, 2017 - 2028 (USD Million)
Fig. 44 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for biotechnology & pharmaceutical companies, 2017 - 2028 (USD Million)
Fig. 45 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for hospitals & clinics, 2017 - 2028 (USD Million)
Fig. 46 Induced pluripotent stem cell (iPSC) production/generation market: Regional outlook and key takeaways
Fig. 47 Induced pluripotent stem cell (iPSC) production/generation market: Regional movement analysis
Fig. 48 North America Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 49 U.S. Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 50 Canada Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 51 Europe Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 52 U.K. Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 53 Germany Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 54 France Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 Italy Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 Spain Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 57 Asia Pacific Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 58 China Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 59 Japan Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 India Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 61 Latin America Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 62 Brazil Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 63 Mexico Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Middle East & Africa Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 65 South Africa Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 66 Saudi Arabia Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Strategy framework
Fig. 68 Market participation categorization
